EBS - Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2020 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS) Q4 2020 Earnings Conference Call February 18, 2021 05:00 p.m. ET Company Representatives Bob Kramer - President, Chief Executive Officer Rich Lindahl - Chief Financial Officer Syed Husain - Senior Vice President, CDMO Business Unit Head Laura Saward - Senior Vice President, Therapeutics Business Unit Head Bob Burrows - VP of Investor Relations Conference Call Participants Brandon Folkes - Cantor Fitzgerald Jacob Hughes - Wells Fargo Securities Jessica Fye - JPMorgan Dana Flanders - Guggenheim Keay Nakae - Chardan Boris Peaker - Cowen Lisa Springer - Singular Research Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Emergent BioSolutions Fourth Quarter 2020 Earnings Conference Call. At this time all participants’ lines are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to management. Please go
For further details see:
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2020 Results - Earnings Call Transcript